Study: Treatment developed to dramatically slow progression of blindness-causing retinal diseases
February 24th 2024Researchers have found that the interactive release of anti-inflammatory drugs depend on the level of retinal degeneration. A customized treatment approach is expected to be developed to reduce patients’ inconvenience of having multiple shots.
EnVision Summit 2024: Tips to launch a personal IPO journey for women in eye care
February 16th 2024Marsha Link, PhD, uses three words—Imagine, Prepare, and Optimize—to encourage women to assess their current leadership journey, strategically plan for advancement, and explore new opportunities for growth and impact in vision care.
Kathryn A. Colby, MD, PhD, looks to the future in ophthalmology and at NYU
February 16th 2024David Hutton of Ophthalmology Times talks with Kathryn A. Colby, MD, PhD, Elisabeth J. Cohen Professor and Chair, NYU Langone Department of Ophthalmology, about the year the department had in 2023 as well as an outlook at advancements in the field of ophthalmology moving forward.